ORIGINAL PAPER
Clinical analysis of X-linked agammaglobulinemia and common variable immunodeficiency in children – what pediatrician should know?
 
More details
Hide details
 
Submission date: 2019-02-25
 
 
Final revision date: 2019-03-07
 
 
Acceptance date: 2019-03-07
 
 
Publication date: 2019-04-29
 
 
Pediatr Pol 2019;94(2):76-80
 
KEYWORDS
TOPICS
ABSTRACT
Aim of the study:
To present relevant clinical features of X-linked agammaglobulinaemia (XLA) and common variable immunodeficiency (CVID) in children, helpful in the everyday practice of paediatricians and general practitioners. To analyse the similarities and differences between XLA and CVID.

Material and methods:
The retrospective analysis of the onset of symptoms, age of clinical diagnosis, basic immunological parameters, and infectious and non-infectious complications in 11 XLA and 21 CVID patients from a single centre was carried out.

Results:
XLA boys presented the first symptoms in the second half of the first year of life. They had extremely low B-cell numbers (mean: 15 cells/µl, 0.45%), and immunoglobulin levels (median IgG: 0.38 g/l). Patients with CVID presented later occurrence of symptoms (median: two years), higher numbers of B cells (mean: 304 cells/µl, 12.5%), and higher immunoglobulin G levels (median: 2.92 g/l), but lower T CD4 cells. IgM and IgA levels were diminished in both groups, with lower values in XLA patients. Relevant differences (p < 0.05) in B-cell numbers and IgG levels between XLA and CVID groups were observed. Severe clinical complications such as chronic lung disease, bronchiectasis, autoimmune disorders, splenomegaly, and lymphadenopathy were more often observed in CVID.

Conclusions:
An earlier onset of symptoms, extremely low B-cell numbers and immunoglobulin levels, and normal numbers of T cells point to XLA. Hypogammaglobulinaemia accompanied by non-infectious complications and diminished CD4 T cells are more suggestive of CVID. Greater awareness between paediatricians and general physicians should lead to a proper diagnosis, earlier treatment, avoidance of severe life-threatening complications, and better quality of life.
REFERENCES (29)
1.
Reust CE. Evaluation of Primary Immunodeficiency Disease in Children. Am Fam Physician 2013; 87: 773-778.
 
2.
Webster ADB. Clinical and immunological spectrum of common variable immunodeficiency (CVID). Iran J Allergy Asthma Immunol 2004; 3: 103-113.
 
3.
Kumar Y, Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. Expert Rev Clin Immunol 2013; 9: 959-977.
 
4.
Piqueras B, Lavenu-Bombled C, Galicier L, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 23: 385-400.
 
5.
Warnatz K, Denz A, Drager R, et al. Severe deficiency of switched memory B cells (CD27(1)IgM(2)IgD(2)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogenous disease. Blood 2002; 99: 1544-1551.
 
6.
Wehr C, Kivioja T, Schmitt C, et al. The EUROClass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111: 77-85.
 
7.
Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immunol Pract 2013; 1: 545-556.
 
8.
Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308-316.
 
9.
Bruton O. Agammaglobulinemia. Pediatrics 1952; 9: 722-728.
 
10.
Pac M, Mikoluc B, Pietrucha B, et al. Clinical and immunological analysis of patients with X-linked agammaglobulinemia – single center experience. Centr Eur J Immunol 2013; 38: 367-371.
 
11.
Plebani A, Soresina A, Rondelli R, et al. Clinical, Immunological, and Molecular Analysis in a Large Cohort of Patients with X-linked Agammaglobulinaemia: An Italian Multicenter Study. Clin Immunol 2002; 104: 221-230.
 
12.
Abolhassani H, Sagvand TB, Shokuhfar T, et al. A review on guidelines for management and treatment of common variable immunodeficiency. Exp Rev Clin Immunol 2013; 9: 561-574.
 
13.
Bonilla FA, Barlan I, Chapel H, et al. International consensus document (ICON): common variable immunodeficiency. J Allergy Clin Immunol Pract 2016; 4: 38-57.
 
14.
Gathmann B, Mahlaoui N, Gerard L, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134: 116-126.
 
15.
Mohammadinejad P, Aghamohammadi A, Abolhassani H, et al. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Invest Allergol Clin Immunol 2012; 22: 208-214.
 
16.
Toth B, Volokha A, Mihas A, et al. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: A cohort study. Mol Immunol 2009; 46: 2140-2146.
 
17.
Park MA, Li JT, Hagan JB. Common variable immunodeficiency: a new look at an old disease. Lancet 2008; 372: 489-502.
 
18.
Piatosa B, Pac M, Siewiera K, et al. Common variable immune deficiency in children – clinical characteristics depending on defect in peripheral B cell maturation. J Clin Immunol 2013; 33: 731-741.
 
19.
Pac M, Bernatowska E. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland. Eur J Pediatr 2016; 175: 1099-1105.
 
20.
Hernandez-Trujillo V, Scalchunes C, Cunningham-Rundles C, et al. Autoimmunity and inflammation in X-linked agammaglobulinaemia. J Clin Immunol 2014; 34: 627-632.
 
21.
Tavakol M, Kouhi A, Abolhassani H, et al. Otological findings in pediatric patients with hypogammaglobulinemia. Iran J Allergy Asthma Immunol 2014; 13: 166-173.
 
22.
Aghamohammadi A, Allahverdi A, Abolhassani H, et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2009; 15: 289-295.
 
23.
Abolhassani H, Amirkhasani D, Parvaneh N, et al. Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2013; 23: 323-329.
 
24.
Pac M, Bernatowska E, Kierkus J, et al. Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinaemia in children – 34-year experience of a single center. Arch Med Sci 2017; 13: 412-417.
 
25.
Boileau J, Mouillot G, Gerard L, et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimm 2011; 36: 25-32.
 
26.
Seidel MG. Autoimmune and other cytopenias in primary immunodeficiencies: patomechanism, novel differential diagnoses, and treatment. Blood 2014; 124: 2337-2344.
 
27.
Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimm Rev 206; 5: 465-470.
 
28.
Notarangelo LD. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology 2009; 139-143.
 
29.
Grześk E, Dąbrowska A, Urbańczyk A, et al. Pospolity zmienny niedobór odporności – choroba o wielu obliczach. Pediatr Pol 2018; 93: 186-191.
 
Journals System - logo
Scroll to top